Małgorzata Lewandowska-Szumieł – VJRegenMed

Future directions in tissue engineering

Simon Ng — Wed, 05 Jan 2022 17:32:26 +0000

Małgorzata Lewandowska-Szumieł, PhD, Medical University of Warsaw, Warsaw, Poland, gives her insights on where the field of tissue engineering is headed. She emphasizes the vast research potential of various biomaterials, and different stimuli they can be subjected to. The development of novel bioreactors additionally present new opportunities for the field in terms of production. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Overcoming challenges in tissue engineering

Simon Ng — Wed, 05 Jan 2022 17:32:26 +0000

Małgorzata Lewandowska-Szumieł, PhD, Medical University of Warsaw, Warsaw, Poland, provides an overview of remaining issues that need to be addressed in the field of tissue engineering. Animal models may not be as reliable due to the fundamental differences in human and animal cells and Prof. Lewandowska-Szumieł highlights need for carefully designed clinical trials as a result, as well the potential cost of tissue engineered products. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Barriers to tissue engineering research in academia

Simon Ng — Mon, 15 Nov 2021 15:14:42 +0000

Małgorzata Lewandowska-Szumieł, PhD, Medical University of Warsaw, Warsaw, Poland, discusses problems academics face in the field of tissue engineering. As tissue engineering products are classed as medicinal products, research laboratories must face increased regulations and adhere to good manufacturing practice (GMP) guidelines, increasing costs. Prof. Lewandowska-Szumieł additionally highlights the need for specialized research grants and describes her experiences in conducting clinical trials investigating adipose-derived stem cells in healing foot ulcers. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).